Franchise Lead, Rare Disease Therapeutics (up to 20m JPY)

The Director, Growth Hormone Franchise Lead will lead the strategy and execution for the growth hormone portfolio, focusing on Ngenla's success in Japan. The role involves managing cross-functional teams, driving brand growth, and building key stakeholder relationships in the rare disease market.
Client Details
This global biopharmaceutical leader is committed to advancing innovative therapies in rare and complex diseases, offering a dynamic, collaborative environment where you can make a meaningful impact on patient outcomes.
Description
* Lead the development and execution of the rare disease portfolio strategy, driving market leadership and ensuring alignment across brand marketing and Health Solution Partners to achieve business goals.
* Manage and develop a team of 10, fostering a collaborative environment to drive high performance, while implementing innovative, omnichannel marketing strategies to enhance brand visibility and engagement in the rare disease therapeutic area.
* Build and maintain strong relationships with internal stakeholders, external KOLs, and HCPs, ensuring alignment on educational initiatives, regulatory compliance, and maximizing business impact.
Profile
* Proven Leader: Experienced in developing and executing strategies, managing cross-functional teams, and driving growth in the rare disease space.
* Innovative Marketer: Skilled in implementing omnichannel marketing strategies and using analytics to enhance brand success and customer engagement.
* Relationship Builder: Strong communicator with the ability to build partnerships with internal teams, KOLs, and HCPs.
Job Offer
Career Growth and Impact: The opportunity to lead a high-impact rare disease portfolio, drive innovation in a dynamic therapeutic area, and work in a collaborative, values-driven environment that supports professional development and leadership growth.
To apply online please click the 'Apply' button below. For a confidential discussion about this role please contact Dr. Philipp Berndt on +813 6832 8945.